期刊文献+

贲门癌患者外周血CD4^+CD25^hiCD127^low调节性T细胞水平及其临床意义

Clinical significance of CD4^+CD25^hiCD127^low regulatory T cells in the peripheral blood of patients with cardiac cancer
原文传递
导出
摘要 目的 探讨贲门癌患者的免疫功能异常及其临床意义.方法 采用流式细胞术(FCM)和酶联免疫吸附(ELISA)方法分别检测56例贲门癌患者、15名健康人外周血中CD4^+CD25^hiCD127^lowc调节性T细胞(Treg细胞)和血清IL-10、TGF-β1水平,结合临床资料进行分析.结果 56例贲门癌患者外周血中CD4^+CD25^hiCD127lowTreg细胞占CD4^+淋巴细胞的比例为(5.73±1.56)%,与健康对照组的(4.45±1.06)%相比,差异有统计学意义(P〈0.01);血清中IL-10和TGF-β1含量均明显高于健康对照(P〈0.05).贲门癌患者外周血CD4^+CD25^hiCD127low Treg细胞水平与血清IL-10和TGF-β1含量呈正相关.贲门癌患者外周血CD4^+CD25^hiCD127low Treg细胞数量与患者临床分期、淋巴结转移有关.结论 贲门癌患者外周血中CD4^+CD25^hiCD127low Treg细胞表达增高,与临床分期有关,提示Treg水平异常与贲门癌的发生发展密切相关. Objective To analyse the dysfunction of immunity and clinical significance in patients with cardiac cancer. Methods The level of CD4^+CD25^hiCD127^low cells were detected by flow cytometry (FCM), and serum IL-10 and TGF-β1 levels were determined by enzyme linked immunosorbent assay (ELISA) kit in 56 patients with cardiac cancer.15 healthy volunteers were tested as normal controls. The clinical data of each patient were collected and analyzed. Results There was a significantly higher percentage of CD4^+CD25^hiCD127^low cells in patients with cardiac cancer(5.73±1.56)% than that(4.45±1.06)% of healthy volunteers (P 〈0.01). The IL-10 and TGF-β1 levels in the serum of patients with cardiac cancer were also significantly higher than that of healthy volunteers(P 〈0.05). There was a positive correlation between levels of IL-10, TGF-β1 and the levels of CD4^+CD25^hiCD127^lowcells. The number of CD4^+CD25^hiCD127^low regulatory T cells in the peripheral blood of cardiac cancer patients were significantly correlated with clinical stages and metastasis lymph node. Conclusion The CD4^+CD25^hiCD127^low cells in the peripheral blood of cardiac cancer patients is significantly increased in comparison with that in healthy volunteers, and was also correlated with different stages. The abnormal levels of CD4^+CD25^hiCD127^low cells may be related to tumor progression in patients with cardiac eancer.
出处 《肿瘤研究与临床》 CAS 2010年第5期303-305,共3页 Cancer Research and Clinic
关键词 胃肿瘤 T细胞 调节性 CD4^+CD25^hiCD127^low Cardiac cancer T cells, regulatory CD4^+CD25^hiCD127^low
  • 相关文献

参考文献12

  • 1Sakaguehi S,Sakaguehi N,Asano M,et al.Immunologic self-tolerance various autoimmune disease.J Immunol,1995,155:1151-1164.
  • 2Shevach EM.Certified professionals:CD4^+CD25^+ suppressor T cells.J Exp Med,2001,193:41-46.
  • 3Lim HW,Hillsamer P,Banham AH,et al.Cutting edge:direct suppression of B cells by CD4^+CD25^+ relgulatory T cells.J Immunol,2005,175:4180-4183.
  • 4Ichiham F,Kono K,Takahashi A,et al.Inereased populations of regulatory T cells in peripheral blood and tinter-infiltrating lymphocytes in patients with gastric and esophageal cancers.Clin Cancer Res,2003,9:4404-4408.
  • 5Wolf AM,wolf D,Steurer M,et al.Increase in regulatory T cells in the peripheral blood of cancer patients.Clin Cancer Res,2003,9:606-612.
  • 6Liyange UK,Moore TT,Joo HC.et al.Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.Immunology,2002,169:2756-2761.
  • 7Okita R,Saeki T,Takashima S,et al.CD4^+CD25^+ regulatory T cells in the perioheral blood of patienls with breast cancer and non-Bmall cell lung cancer.Oncol Rep,2005,14:1269-1273.
  • 8Viguier M,Lemaitre F,Verola O,et al.Foxp3 expressing CD4^+CD25 (hig) regulatory T cells are overrepresented in humanmetastaticmelanoma lymph nodes and inhibit the function of infiltrating T cells.J Immunol,2004,173:1444-1453.
  • 9章圣辉,韩义香,吴建波,胡晓霞.子宫颈癌患者外周血CD_4^+ CD_(25)^+CD_(127)^(lo/-)调节性T淋巴细胞的含量及肿瘤免疫水平检测[J].中华妇产科杂志,2007,42(6):419-420. 被引量:12
  • 10Hartigan-O'Connor DJ,Peon C,Sinclair E,et al.Human CD4^+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127),allowing consistent identification and sorting of live cells.J Immunol Methods,2007,319:41-52.

二级参考文献8

  • 1刘俊田,岳杰,任秀宝,李慧.乳腺癌患者外周血CD_4^+CD_(25)^+调节性T细胞的检测及意义[J].中华肿瘤杂志,2005,27(7):423-425. 被引量:30
  • 2Chen ML, Pittet MJ, Gorelik L, et al. Regulatory T cells suppress tumor-specific CDs T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A, 2005, 102:419-424.
  • 3Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4^+ T reg cells. J Exp Med, 2006, 203:1701-1711.
  • 4Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol, 2003, 171:6323- 6327.
  • 5Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med, 2006, 203 : 1693-1700.
  • 6Roncador G, Brown PJ, Maestre L, et al. Analysis of FOXP3 protein expression in human CD4^+ CD25^+ regulatory T cells at the single-cell level. Eur J Immunol, 2005, 35 : 1681-1691.
  • 7Miller AM, Lundberg K, Ozenci V, et al. CD4^+ CD25^hegh sigh T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J Immunol, 2006, 177:7398-7405.
  • 8Ichihara F, Kono K, Takahashi A, et al. Increased populations of regulatory T cells in peripheral blood and tumor-infihrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res, 2003, 9:4404--4408.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部